A detailed history of Advisor Group Holdings, Inc. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 742 shares of LXRX stock, worth $615. This represents 0.0% of its overall portfolio holdings.

Number of Shares
742
Previous 742 -0.0%
Holding current value
$615
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$1.54 - $2.28 $1,067 - $1,580
-693 Reduced 48.29%
742 $1,000
Q1 2024

May 10, 2024

BUY
$1.3 - $3.58 $53 - $146
41 Added 2.94%
1,435 $3,000
Q4 2023

Feb 12, 2024

SELL
$1.0 - $1.53 $5,850 - $8,950
-5,850 Reduced 80.76%
1,394 $2,000
Q3 2023

Nov 13, 2023

BUY
$1.06 - $2.33 $928 - $2,041
876 Added 13.76%
7,244 $7,000
Q2 2023

Aug 10, 2023

BUY
$2.15 - $3.49 $7,494 - $12,166
3,486 Added 120.96%
6,368 $14,000
Q1 2023

May 12, 2023

SELL
$1.99 - $2.68 $780 - $1,050
-392 Reduced 11.97%
2,882 $7,000
Q4 2022

Feb 10, 2023

SELL
$1.8 - $2.56 $612 - $870
-340 Reduced 9.41%
3,274 $6,000
Q3 2022

Nov 14, 2022

BUY
$1.94 - $3.43 $1,984 - $3,508
1,023 Added 39.48%
3,614 $8,000
Q2 2022

Aug 10, 2022

BUY
$1.31 - $2.69 $142 - $293
109 Added 4.39%
2,591 $4,000
Q1 2022

May 04, 2022

BUY
$1.95 - $3.89 $1,868 - $3,726
958 Added 62.86%
2,482 $4,000
Q3 2021

Nov 05, 2021

BUY
$3.38 - $5.35 $676 - $1,070
200 Added 15.11%
1,524 $7,000
Q2 2021

Aug 02, 2021

SELL
$4.12 - $5.87 $1,503 - $2,142
-365 Reduced 21.61%
1,324 $6,000
Q1 2021

May 13, 2021

SELL
$3.45 - $9.09 $348 - $918
-101 Reduced 5.64%
1,689 $10,000
Q4 2020

Feb 10, 2021

BUY
$1.05 - $3.67 $678 - $2,370
646 Added 56.47%
1,790 $5,000
Q3 2020

Nov 12, 2020

SELL
$1.44 - $2.1 $2,125 - $3,099
-1,476 Reduced 56.34%
1,144 $1,000
Q2 2020

Aug 14, 2020

BUY
$1.75 - $2.3 $656 - $862
375 Added 16.7%
2,620 $5,000
Q1 2020

May 18, 2020

BUY
$1.8 - $4.28 $4,041 - $9,608
2,245 New
2,245 $4,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.